Apolipoprotein A-I-stimulated secretion of apolipoprotein E by human foam cell macrophages.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/151650

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Atherosclerosis is the disease which causes narrowings in arteries underlying such serious conditions as heart attack and stroke. A key component of the formation of atherosclerotic narrowings in arteries is the accumulation of fat-filled cells called foam cell macrophages. These foam cells can be stimulated to secrete a special molecule called apolipoprotein E (or apo E), which reduces the amount of atherosclerosis. We have found that we can stimulate foam cells to secrete this protein by adding to them another molecule called apo A-I. This project will investigate how apo A-I stimulates the foam cells to secrete apo E. In this way we will be able to regulate the secretion of apo E, and be able to increase its secretion. This may result in our being able to treat or prevent atherosclerosis.

Funded Activity Details

Start Date: 01-01-2001

End Date: 01-01-2002

Funding Scheme: NHMRC Project Grants

Funding Amount: $201,208.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutrigenomics and personalised nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

apolipoprotein A-I | apolipoprotein E | atherosclerosis | cholesterol | coronary heart disease | macrophage | stroke

Related Links